Skip to main content

Aspire-Lakewood Holdings, Inc.

ASBP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001847345

No open-market purchases or sales by Aspire-Lakewood Holdings, Inc. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $250.9K in total; no superinvestor holds it.

Other share classesASBPW

Q1 2026 vs. Q4 2025

How the institutions holding Aspire-Lakewood Holdings, Inc. changed between Q4 2025 and Q1 2026.

All holders in Q1 2026All holders in Q4 2025

13F holders of ASBP: Q4 2025 compared with Q1 2026
MeasureQ4 2025Of which not filed for Q1 2026Q1 2026Change
Holders30315−12
Shares6.82M680.6K378.6K−5.76M (−93.8%)
Value$899.8K$89.8K$371.9K−$438.1K (−54.1%)

3 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (7)

Institutions that held Aspire-Lakewood Holdings, Inc. at the end of Q1 2026 but not at the end of Q4 2025.

Institutions new to ASBP in Q1 2026
InstitutionSharesValue% of portfolio
Morgan Stanley76,955$79.3K0.00%
Vanguard Capital Management LLC7,859$8.10K0.00%
Toronto Dominion Bank5,000$5.15K0.00%
Vanguard Fiduciary Trust Co2,856$2.94K0.00%
Citigroup Inc1,846$1.90K0.00%
SBI Securities Co., Ltd.1$10.00%
Caitong International Asset Management Co., Ltd1$10.00%

Sold out (19)

Institutions that held Aspire-Lakewood Holdings, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.

Not filed for Q1 2026 yet (3)

Institutions that held Aspire-Lakewood Holdings, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ASBP in Q4 2025 that haven't filed for Q1 2026
InstitutionShares, Q4 2025Value, Q4 2025
Vanguard Group Inc428,552$56.6K
Antara Capital LP202,897$26.8K
CIBC Private Wealth Group, LLC49,129$6.48K